J. J. G. Egan (Dublin, Ireland), C. Albera (Turin, Italy)
Clinical features of combined pulmonary fibrosis and emphysema Y. Amano, Y. Yamauchi, H. Kage, T. Nagase (Japan)
| |
Combined pulmonary fibrosis and emphysema: A report from the Hellenic Interstitial Lung Diseases group Z. Daniil, F. Malli, M. Dimadi, K. Antoniou, A. Tzouvelekis, F. Drakopanagiotakis, F. Kokkinis, G. Margaritopoulos, K. Manika, D. Bouros, D. Papakosta (Larissa, Athens, Heraklion, , Thessaloniki, Greece)
| |
Determination of pulmonary hypertension degree in patients with interstitial lung diseases V. Osipenko, E. Kogan, A. Shechter, O. Kichigina, E. Popova (Moscow, Russian Federation)
| |
Fibrosing organising pneumonia – Histological features of a proposed new clinicopathological entity A. Rice, H. Manganas, T. Maher, E. Renzoni, D. Hansell, S. Desai, A. Wells, A. Nicholson (London, United Kingdom)
| |
Limiting factors at maximal exercise in sarcoidosis and idiopathic pulmonary fibrosis C. Lamberto, H. Nunes, A. Buvry, D. Valeyre (Bobigny, Bondy, France)
| |
Arterial stiffness in patients with idiopatic intersticial pneumonia N. Karoli, A. Rebrov (Russian Federation)
| |
All-round tissue verification of the diffuse parenchymal lung diseases via videothoracoscopic biopsy A. Pismennyy, E. Korymasov, A. Tepikin (Russian Federation)
| |
Opportunities of SPECT-CT in the diagnosis of vascular complications of interstitial lung diseases A. Speranskaya, V. Amosov, L. Novikova, V. Zolotnitskaya, O. Lukina (Saint- Petersburg, Russian Federation)
| |
Potential causes of acute deterioration in patients with interstitial lung disease J. Su, H. Dai, Q. Ye, S. Zhang, C. Ban, M. Zhu (Beijing, China)
| |
Longitudinal clinico-physiological behaviour of interstitial lung disease in the idiopathic inflammatory muscle syndromes A. M. Higton, A. N. Colebatch, S. Grubnic, I. Vlahos, K. McNulty, K. O‘Reilly, C. Edwards, P. D. Kiely, F. Chua (London, United Kingdom)
| |
Quality of life in interstitial lung disease K. Brignall, A. Patel, I. Higginson, S. Singh, M. Morgan, A. Wells, S. Birring (London, Leicester, United Kingdom)
| |
The frequency of pulmonary embolism in cases with interstitial lung diseases N. Demir Firat, G. Köycü, I. Çayli, D. Karnak, O. Kayacan (Ankara, Turkey)
| |
Thoracic involvement in multicentric Castleman‘s disease S. Ikushima, K. Kondoh, K. Satake, M. Masuo, H. Kamiya, T. Takemura, M. Oritsu (Tokyo, Japan)
| |
The chance of developing lung cancers are more in combined pulmonary fibrosis & emphysema than emphysema alone S. M. A. Al Mamun (Dhaka, Bangladesh)
| |
Predictors of bleomycin toxicity A. Abbott, L. Morgan, E. Veitch, L. Seccombe (Concord, Australia)
| |
Cigarette smoking contributes to idiopathic pulmonary fibrosis associated with emphysema Q. Ye, H. Dai, K. Huang, B. Lou, C. Wang (Beijing, China)
| |
Gender differences in an Irish sarcoidosis population M. Saleem, K. Sharma, A. Talbot, R. Rutherford, A. O‘Regan, J. J. Gilmartin (Galway, Ireland)
| |
Interstitial lung disease and gastro-esophageal reflux L. H. Zhao, H. Dai, S. Zhang, M. Zhu, Q. Ye, Z. M. Shang (Beijing, China)
| |
Does CT pattern predict dyspnoea in sarcoidosis? S. de Boer, D. Milne, J. Kolbe, M. Wilsher (Auckland, New Zealand; , United Kingdom)
| |
Expression profiling in sarcoidosis, EAA and IPF M. Sterclova, M. Vasakova, L. Kolesar, I. Striz (Prague, Czech Republic)
| |